A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction
NCT05891613
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Breast Reduction
Interventions
DRUG:
Bupivacaine Hydrochloride
DRUG:
Liposomal Bupivacaine
Sponsor
Mayo Clinic